KCNK10 and migraine disorder: Both TREK-1 and TREK-2 are widely expressed inthe mammalian CNS, as well as the periphery, and activation of eitherTREK-1, TREK-2 or both channels have potential therapeutic utilityin pain, migraine, ischemia, and arrhythmia among others.